Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06765356 · ClinicalTrials.gov registry record · Phase 4
Pragmatic Evaluation of a Pentaspline Pulsed Field Ablation System to Treat Atrial Fibrillation and Related Arrhythmias
A Phase 4 study of Paroxysmal Atrial Fibrillation and Persistent Atrial Fibrillation, sponsored by Vivek Reddy.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 275
- Enrollment target
- 5
- Study locations
NCT06765356 is a Phase 4 study of Paroxysmal Atrial Fibrillation and Persistent Atrial Fibrillation that is actively recruiting participants, run by Vivek Reddy. The registered enrollment target is 275 participants, below the 848-participant average among 24 other Paroxysmal Atrial Fibrillation trials with a reported enrollment target (68% lower). The trial reports 5 study locations across 5 states.
The verdict
NCT06765356, a Phase 4 study of Paroxysmal Atrial Fibrillation and Persistent Atrial Fibrillation, is actively recruiting participants, sponsored by Vivek Reddy.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 275 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this pragmatic study is to evaluate the safety, performance and effectiveness of the FARAPULSE catheter system (FARAWAVE catheter used in combination with the FARASTAR generator), to treat patients with atrial fibrillation during clinically-indicated ablation procedures
Conditions Studied
Interventions
- DEVICE Farapulse Catheter System
- DRUG Low-dose Colchicine
Study Locations (5)
Arkansas
- Arrhythmia Research Group - Jonesboro
Florida
- Naples Comprehensive Health - Naples
New York
- The Mount Sinai Hospital - New York
Pennsylvania
- UPMC Pinnacle Hospitals - Harrisburg
South Carolina
- Trident Medical Center - North Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 275 participants |
| Start Date | 2025-04-15 |
| Est. Completion | 2027-03-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06765356
The ClinicalTrials.gov registry entry for NCT06765356 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 275 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 848-participant average among 24 other Paroxysmal Atrial Fibrillation trials with a reported enrollment target (68% lower). The listed sponsor is Vivek Reddy, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Paroxysmal Atrial Fibrillation appearing as the primary indexed condition, and to 2 interventions - of which Farapulse Catheter System is the first listed.
NCT06765356 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Arkansas, Florida, New York.
Frequently Asked Questions
What is clinical trial NCT06765356 about?
NCT06765356 is a clinical study titled "Pragmatic Evaluation of a Pentaspline Pulsed Field Ablation System to Treat Atrial Fibrillation and Related Arrhythmias". The purpose of this pragmatic study is to evaluate the safety, performance and effectiveness of the FARAPULSE catheter system (FARAWAVE catheter used in combination with the FARASTAR generator), to treat patients with atrial fibrillation during clinically-indicated ablation procedures
What is the current status of trial NCT06765356?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 275 participants. The study started on 2025-04-15. Estimated completion is 2027-03-30.
What conditions does trial NCT06765356 study?
This clinical trial studies the following conditions: Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation, Long-standing Persistent Atrial Fibrillation.
What interventions are being tested in trial NCT06765356?
The interventions under investigation include: Farapulse Catheter System (DEVICE), Low-dose Colchicine (DRUG).
Who is sponsoring clinical trial NCT06765356?
This trial is sponsored by Vivek Reddy, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06765356 being conducted?
This trial has 5 study locations across Arkansas, Florida, New York, Pennsylvania, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Paroxysmal Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Comparison of Antiarrhythmic Drug Therapy and Radio Frequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation
COMPLETED · Phase 4
-
Evaluation of VISITAG SURPOINT™ Module With External Processing Unit (EPU)
COMPLETED · Phase 4
-
ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients
RECRUITING · NA
-
Determinates of Atrial Tracking and Prevalence of Atrial Fibrillation in the Micra AV2 (DANCE AFIB)
RECRUITING
-
STOP AF First Post-Approval Study
RECRUITING
-
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
RECRUITING
Explore more on PlainTrial
Paroxysmal Atrial Fibrillation
All registered trials for this condition
Persistent Atrial Fibrillation
All registered trials for this condition
Arkansas
All trials with a study site in Arkansas
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.